Novocure Historical Financial Ratios
| NVCR Stock | USD 29.72 1.07 3.73% |
Novocure is lately reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 44.14 will help investors to properly organize and evaluate Novocure financial condition quickly.
Novocure |
About Novocure Financial Ratios Analysis
NovocureFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Novocure investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Novocure financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Novocure history.
Novocure Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Novocure stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Novocure sales, a figure that is much harder to manipulate than other Novocure multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from Novocure's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.At this time, Novocure's Debt To Equity is relatively stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 63.83 | 58.54 | 43.87 | 44.14 | PTB Ratio | 18.92 | 17.4 | 4.38 | 4.16 |
Novocure fundamentals Correlations
Click cells to compare fundamentals
Novocure Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Novocure fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 23.32 | 35.33 | 14.51 | 14.27 | 3.12 | 2.96 | |
| Ptb Ratio | 37.62 | 36.65 | 18.92 | 17.4 | 4.38 | 4.16 | |
| Days Sales Outstanding | 61.15 | 71.39 | 63.83 | 58.54 | 43.87 | 44.14 | |
| Book Value Per Share | 2.24 | 4.72 | 3.97 | 4.22 | 3.41 | 2.53 | |
| Free Cash Flow Yield | 0.001969 | 0.00482 | 0.007544 | 0.001228 | (0.0632) | (0.0664) | |
| Operating Cash Flow Per Share | 0.27 | 0.98 | 0.8 | 0.29 | (0.69) | (0.72) | |
| Capex To Depreciation | 1.24 | 1.64 | 2.36 | 2.01 | 2.47 | 2.2 | |
| Pb Ratio | 37.62 | 36.65 | 18.92 | 17.4 | 4.38 | 4.16 | |
| Ev To Sales | 23.29 | 35.75 | 15.2 | 15.15 | 3.82 | 3.63 | |
| Free Cash Flow Per Share | 0.17 | 0.83 | 0.57 | 0.0901 | (0.94) | (0.99) | |
| Roic | (0.002039) | 0.0257 | (0.0511) | (0.1) | (0.27) | (0.28) | |
| Inventory Turnover | 3.74 | 3.88 | 4.7 | 3.91 | 3.36 | 2.59 | |
| Net Income Per Share | (0.0744) | 0.2 | (0.56) | (0.88) | (1.95) | (1.85) | |
| Days Of Inventory On Hand | 97.63 | 93.98 | 77.61 | 93.34 | 108.56 | 138.46 | |
| Payables Turnover | 2.4 | 1.99 | 1.58 | 1.35 | 1.36 | 1.5 | |
| Sales General And Administrative To Revenue | 0.3 | 0.25 | 0.22 | 0.24 | 0.32 | 0.31 | |
| Capex To Revenue | 0.0298 | 0.0303 | 0.0452 | 0.0397 | 0.0532 | 0.0505 | |
| Cash Per Share | 3.35 | 8.35 | 9.07 | 9.26 | 8.56 | 8.99 | |
| Pocfratio | 307.82 | 176.15 | 93.84 | 249.35 | (21.66) | (22.74) | |
| Interest Coverage | (0.0666) | 1.62 | (12.89) | (26.85) | (70.16) | (73.67) | |
| Capex To Operating Cash Flow | 0.39 | 0.15 | 0.29 | 0.69 | (0.37) | (0.39) | |
| Pfcf Ratio | 507.85 | 207.47 | 132.55 | 814.09 | (15.82) | (15.03) | |
| Days Payables Outstanding | 152.11 | 183.86 | 230.67 | 270.72 | 268.57 | 263.19 | |
| Income Quality | (3.68) | 5.01 | (1.42) | (0.33) | 0.35 | 0.39 | |
| Roe | (0.57) | (0.0332) | 0.0416 | (0.14) | (0.21) | (0.6) | |
| Ev To Operating Cash Flow | 307.3 | 178.26 | 98.27 | 264.58 | (26.51) | (27.83) | |
| Pe Ratio | (1.1K) | 881.72 | (133.09) | (82.96) | (7.67) | (8.06) | |
| Return On Tangible Assets | (0.19) | (0.0151) | 0.0188 | (0.0512) | (0.0777) | (0.18) | |
| Ev To Free Cash Flow | 507.0 | 209.96 | 138.81 | 863.82 | (19.36) | (18.39) | |
| Earnings Yield | (8.82E-4) | 0.001134 | (0.007514) | (0.0121) | (0.13) | (0.12) | |
| Net Debt To E B I T D A | (0.97) | 4.63 | (9.55) | (7.43) | (2.02) | (2.12) | |
| Current Ratio | 5.1 | 8.8 | 7.53 | 7.0 | 5.78 | 7.95 | |
| Tangible Book Value Per Share | 2.24 | 4.72 | 3.97 | 4.22 | 3.41 | 2.53 | |
| Receivables Turnover | 5.97 | 5.11 | 5.72 | 6.24 | 8.32 | 7.87 | |
| Graham Number | 1.94 | 4.57 | 7.1 | 9.16 | 12.21 | 9.1 | |
| Shareholders Equity Per Share | 2.24 | 4.72 | 3.97 | 4.22 | 3.41 | 2.53 | |
| Debt To Equity | 0.69 | 0.9 | 1.37 | 1.28 | 1.57 | 1.65 | |
| Capex Per Share | 0.11 | 0.15 | 0.23 | 0.2 | 0.25 | 0.13 |
Additional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.